Global Adult Vaccines Market is expected to increase at a CAGR of around 6% over the next five years; Finds New Report

The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 6% over the next five years. Adults are as likely as children to die from diseases that they can be immunized. For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related complications in the elderly. Adult vaccines continue to be one of the growing segment for pharmaceutical companies. The driving factors for adult vaccines growth are an increasing acceptance of adult vaccines and the public health focus on flu prevention, as well as introductions of new vaccines. The vaccines industry also faces hindrances such as vaccine safety, shortages and delays, vaccine development time line as well as entry barriers for new manufacturers.

Adult Vaccines Market - Disease Wise Analysis

The influenza vaccines capture maximum share of the total adult vaccines market. It is the most popular and accepted vaccination amongst adults. The hepatitis vaccines account for second highest share of the total adult vaccines market in 2015. The HPV/cervical cancer vaccines and pneumococcal vaccines captures the third and fourth highest share of the adult vaccines market respectively in 2015. While vaccines for zoster shingles and DTP are also gaining ground in adult vaccines market landscape.

Adult Vaccines Market - Company Analysis

Note: Novartis divested its non-influenza vaccine business to GlaxoSmithKline (GSK) and CSL acquired Novartis influenza vaccines business.

In 2010, GSK was the leader in the adult vaccines market but it lost the leadership position to Merck. Sanofi Pasteur stands at the second position in the adult vaccines market landscape. GSK slipped to third position in the global adult vaccines market in 2014. While Pfizer stands at the fourth spot in the adult vaccines market landscape.

Adult Vaccines Market - Disease Wise Company Sales Analysis

GSK generates maximum adult vaccines sales from Hepatitis and DTP vaccines, while Sanofi Pasteur remains focused on maintaining its leadership in the influenza vaccines market. The cervical cancer and zoster shingles vaccines contributes maximum share of the total Merck adult vaccines sales. Novartis main source of adult vaccines sales revenue is the influenza vaccines.

In 2011, Sanofi Pasteur replaced GSK and became the dominant player in the influenza vaccines landscape, while in the cervical cancer vaccines market, Merck is at the forefront and is expected to maintain its dominancy over a longer period of time. GSK is the clear leader in hepatitis vaccines market.

Adult Vaccines Market - Regional Distribution

On a regional basis, the United States comprises the single largest market for adult vaccines being closely followed by Europe. Japan’s adult vaccines market share is expected to remain flat during the forecasting period, while China’s adult vaccines market is likely to show continuous growth. South America and India are competing closely with each other to grab maximum share of the adult vaccines market pie.

This is the 2nd edition report on Adult Vaccines Market by Publisher RESEARCH. The report titled “Global - Adult Vaccines Market, Company Analysis and Forecast to 2021” is a 239 Page report with 141 Figures and 12 Tables. This report studies in detail the adult vaccines market disease wise, company wise sales analysis and strategic alliances, mergers and acquisitions along with growth drivers and hindrances for the vaccines market landscape.

The 9 Diseases covered in the report are analyzed from four viewpoints:

1. Adult Vaccines Market (2007 - 2021)

2. Number of Adults Vaccinated (2007 - 2021)

3. Number of Doses (2007 - 2021)

4. Company Sales Share (2010 - 2021)

The 7 Companies covered in the report are analyzed from two viewpoints:

1. Disease Wise - Adult Vaccines Sales (2007 - 2021)

2. Strategic Alliances

The 8 Region covered in the report are analyzed from one viewpoint:

1. Adult Vaccines Market (2011 - 2021)

Global Adult Vaccines Market, Number of Adults Vaccinated and Doses - Disease Wise Analysis to 2021 (9 Disease Analysed)

1. Influenza

2. Cervical Cancer

3. Zoster Shingles

4. Pneumococcal

5. Meningococcal

6. MMRV

7. Hepatitis

8. DTP

9. Travel and Miscellaneous

Global Adult Vaccines Market - Company Analysis to 2021 (7 Companies Analysed)

1. GlaxoSmithKline

2. Sanofi Pasteur

3. Merck

4. Novartis

5. Pfizer

6. bioCSL (Seqirus)

7. Protein Sciences

8. Other Companies

Global Adult Vaccines Market - Regional Distribution to 2021 (8 Region Analysed)

1. United States

2. North America/Caribbean

3. South America

4. Europe

5. Japan

6. India

7. China

8. Rest of the World

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Spanning over 239 pages “Global - Adult Vaccines Market, Company Analysis and Forecast to 2021” report covers Executive Summary, Global - Adult Vaccines Analysis and Forecast (2007 - 2021), Global Adult Vaccine Market Share Analysis and Forecast (2010 - 2021), Global Adult Vaccine Market - Disease Wise Analysis, Global Adult Vaccine Market - Company Analysis and Strategic Alliances, Global Adult Vaccine - Disease Wise Company Sales and Forecast (2007 - 2021), Global Adult Vaccine Market - Regional Distribution (2011 - 2021), Major Vaccine Related Acquisitions (2005-2015), Adult Vaccines Market - Driving Factors, Adult Vaccines Market - Challenges. This report Covered Companies - GlaxoSmithKline, Novartis, Sanofi Pasteur, bioCSL, Merck, Pfizer, Protein Sciences.

For more information Visit at: http://mrr.cm/33E

Related Reports;

Global Proton Therapy Market (Actual and Potential) and Centers Analysis - Visit at - http://mrr.cm/33a

Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021 - Visit at - http://mrr.cm/33R

Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2021 - Global Analysis - Visit at - http://mrr.cm/33D

Influenza Vaccines Market and Forecast - Global Analysis - http://mrr.cm/33z